131 related articles for article (PubMed ID: 3802378)
21. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
Elliott WL; Roberts BJ; Howard CT; Leopold WR
Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790
[TBL] [Abstract][Full Text] [Related]
22. Lack of therapeutic synergism between vincristine and methotrexate in L1210 murine leukemia in vivo.
Bender RA; Nichols AP; Norton L; Simon RM
Cancer Treat Rep; 1978 Jul; 62(7):997-1003. PubMed ID: 688252
[TBL] [Abstract][Full Text] [Related]
23. Improved synthesis and antitumor evaluation of 5,8-dideazaisofolic acid and closely related analogues.
Hynes JB; Yang YC; McGill JE; Harmon SJ; Washtien WL
J Med Chem; 1984 Feb; 27(2):232-5. PubMed ID: 6694171
[TBL] [Abstract][Full Text] [Related]
24. Microwave treatment of intracerebral L1210 leukemia: schedule-dependent partial reversal of the effects of methotrexate.
Chang BK; Huang AT; Joines WT
Bioelectromagnetics; 1981; 2(1):77-80. PubMed ID: 7284044
[TBL] [Abstract][Full Text] [Related]
25. Methotrexate analogues. 34. Replacement of the glutamate moiety in methotrexate and aminopterin by long-chain 2-aminoalkanedioic acids.
Rosowsky A; Bader H; Kohler W; Freisheim JH; Moran RG
J Med Chem; 1988 Jul; 31(7):1338-44. PubMed ID: 2898531
[TBL] [Abstract][Full Text] [Related]
26. Timing- and sequence-dependent synergism between etoposide and methotrexate or etoposide, methotrexate and 5-fluorouracil in advanced leukemia L1210.
Osswald H; Herrmann R; Youssef M
Cancer Lett; 1985 Dec; 29(3):277-82. PubMed ID: 4075296
[TBL] [Abstract][Full Text] [Related]
27. Comparison of transport properties of the reduced folate carrier and folate receptor in murine L1210 leukemia cells.
Sierra EE; Brigle KE; Spinella MJ; Goldman ID
Biochem Pharmacol; 1995 Oct; 50(8):1287-94. PubMed ID: 7488246
[TBL] [Abstract][Full Text] [Related]
28. l-5-formyltetrahydrofolate and l-5-methyltetrahydrofolate rescue in L1210 leukemia treated with high methotrexate doses.
Simile MM; DeMiglio MR; Nufris A; Pascale RM; Muroni MR; Feo F
Res Commun Chem Pathol Pharmacol; 1993 Aug; 81(2):251-4. PubMed ID: 8210704
[TBL] [Abstract][Full Text] [Related]
29. Probenecid inhibition of methotrexate cytotoxicity in mouse L1210 leukemia cells.
Gangji D; Ross WE; Bleyer WA; Poplack DG; Glaubiger DL
Cancer Treat Rep; 1984 Mar; 68(3):521-5. PubMed ID: 6704981
[TBL] [Abstract][Full Text] [Related]
30. Biochemical and antitumor effects of 5,8-dideazaisopteroylglutamate, a unique quinazoline inhibitor of thymidylate synthase.
Fernandes DJ; Bertino JR; Hynes JB
Cancer Res; 1983 Mar; 43(3):1117-23. PubMed ID: 6825083
[No Abstract] [Full Text] [Related]
31. Schedule-dependent synergism of methotrexate and vincristine against murine L1210 leukemia.
Chello PL; Sirotnak FM; Dorick DM; Moccio DM
Cancer Treat Rep; 1979; 63(11-12):1889-94. PubMed ID: 526921
[TBL] [Abstract][Full Text] [Related]
32. Survival of tumor-bearing mice exposed to heavy water or heavy water plus methotrexate.
Laissue JA; Bürki H; Berchtold W
Cancer Res; 1982 Mar; 42(3):1125-9. PubMed ID: 6800646
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of methotrexate polyglutamates in L1210 murine leukemia cells.
Whitehead VM
Cancer Res; 1977 Feb; 37(2):408-12. PubMed ID: 832265
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of dihydrofolate reductase, methotrexate transport, and growth of methotrexate-sensitive and -resistant L1210 leukemia cells in vitro by 5-substituted 2,4-diaminoquinazolines.
Susten SS; Hynes JB; Kumar A; Freisheim JH
Biochem Pharmacol; 1985 Jun; 34(12):2163-7. PubMed ID: 4004934
[TBL] [Abstract][Full Text] [Related]
35. The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate.
Zhao R; Babani S; Gao F; Liu L; Goldman ID
Clin Cancer Res; 2000 Sep; 6(9):3687-95. PubMed ID: 10999762
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of analogues of 5,8-dideazaisofolic acid (IAHQ) modified at positions 2, 4 and 9.
Hynes JB; Hagan RL; Shane B; Freisheim JH
Adv Exp Med Biol; 1993; 338():417-20. PubMed ID: 8304148
[No Abstract] [Full Text] [Related]
37. Uptake and metabolism of 5,8-dideazaisofolic acid in human colon carcinoma cells.
Sobrero AF; McGuire JJ; Bertino JR
Biochem Pharmacol; 1988 Mar; 37(6):997-1001. PubMed ID: 2451526
[TBL] [Abstract][Full Text] [Related]
38. Combined antitumoral effects of pretubulysin and methotrexate.
Kern S; Truebenbach I; Höhn M; Gorges J; Kazmaier U; Zahler S; Vollmar AM; Wagner E
Pharmacol Res Perspect; 2019 Feb; 7(1):e00460. PubMed ID: 30693087
[TBL] [Abstract][Full Text] [Related]
39. New approaches to chemotherapy with folate antagonists: use of leucovorin "rescue" and enzymic folate depletion.
Bertino JR; Levitt M; McCullough JL; Chabner B
Ann N Y Acad Sci; 1971 Nov; 186():486-95. PubMed ID: 4943812
[No Abstract] [Full Text] [Related]
40. Potentiation of methotrexate toxicity by dipyridamole.
Nelson JA; Drake S
Cancer Res; 1984 Jun; 44(6):2493-6. PubMed ID: 6586287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
